HLA
VSTM icon

Hamilton Lane Advisors’s Verastem VSTM Stock Holding History

Hamilton Lane Advisors’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-3,560
Closed -$364K – 64
2014
Q3 		$364K Sell
3,560
-1,667
-32% -$175K 0.12% 44
2014
Q2 		$568K Hold
5,227
– – 0.17% 45
2014
Q1 		$677K Buy
+5,227
New +$834K 0.27% 53

Other funds holding VSTM

PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Hamilton Lane Advisors's VSTM Position: Q4 2014 in Review

Hamilton Lane Advisors sold out of Verastem (VSTM) in Q4 2014, closing a stake of 3,560 shares — an estimated $364K sold.

Hamilton Lane Advisors first reported a position in VSTM in Q1 2014 and held it in 3 quarters. The position peaked at $677K in Q1 2014. 72 funds tracked by Wall St. Rank hold VSTM as of Q4 2014.

  • Hamilton Lane Advisors reported no remaining Verastem position as of Q4 2014 after selling out during the quarter.
  • Hamilton Lane Advisors sold 3,560 Verastem shares in Q4 2014, an estimated $364K.
  • Hamilton Lane Advisors first reported a position in Verastem in Q1 2014 and held it in 3 quarters.
  • Hamilton Lane Advisors's Verastem position peaked at $677K in Q1 2014.
  • 72 funds tracked by Wall St. Rank held Verastem as of Q4 2014.

Based on Hamilton Lane Advisors's 13F filing for Q4 2014, filed 26 Jan 2015.